Bishrut Mukherjee
Direttore/Membro del Consiglio presso Oxford Cannabinoid Technologies Ltd.
Patrimonio netto: 501 $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Clarissa Sowemimo-Coker | F | 44 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | 6 anni |
Karen Lowe | F | 55 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | - |
John Lucas | M | 58 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | 3 anni |
Charanjit Dhillon | F | 66 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | - |
Richard Hathaway | M | 57 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | - |
Indraneil Mahapatra | M | 44 |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 6 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Bishrut Mukherjee
- Contatti personali